Panel Discussion | Are We Ready for Technological Solutions such as Digitally Enabled Cardiac Rehabilitation, and Changing Cath Lab Flow to Change the Practice of Interventional Cardiology?

Monday, March 10, 2025

10:22 AM – 10:37 AM ET

Panel Moderator(s)

Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose
Richard E. Galgon, MD, MS

Principal Consultant
CardioMed Device Consultants, LLC
Waunakee, Wisconsin, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure(s): Bio-T: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cuspa medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medhub AI: Stock-privately held company (Ongoing)
Ramzi Khamis, MD PhD

Consultant Cardiologist. Clinical Director of Cardiology and Cardiothoracic Surgery
Imperial College London and Imperial College Healthcare NHS Trust
London , England, United Kingdom

Disclosure information not submitted.
David F. Kong, MD, AM, DMT

Associate Professor of Medicine
Duke University
Durham, North Carolina, United States

Disclosure information not submitted.
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Disclosure(s): No financial relationships to disclose
Sa'ar Minha, MD

Director, Interventional Cardiology
Shamir Medical Center
Shoham, Israel

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Semih Oktay, PhD

President
Cardiomed Device Consultants
Annapolis, Maryland, United States

Disclosure information not submitted.

Disclosure(s):

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Richard E. Galgon, MD, MS: No financial relationships to disclose

Rafael Beyar, MD, DSc, MPH: Bio-T: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cuspa medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Chaim Shaul Lotan, MD: No financial relationships to disclose

Sa'ar Minha, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)